Ophthalmic Plastic and Reconstructive Surgery · Phoenix, AZ
NPI
1710239751
Since 2012
Specialty
Ophthalmic Plastic and Reconstructive Surgery
Code 207WX0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4800 N 22nd St
Phoenix, AZ, 85016
Phone (602) 955-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$365K
11,553 services
Medicare patients, 2024
771
Average age 75
Drug cost, 2024
$152K
1,417 prescriptions
Company payments, 2025
$295
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Grant H Moore was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,314 times for 34 patients. In total Grant H Moore billed 11,553 services in 60 codes, and Medicare paid $365K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,314 | 34 | $4.90 | $46K |
| 92285 Standard X-ray | Office | 392 | 384 | $16.07 | $6,300 |
| 99213 Office E&M - Established | Office | 386 | 338 | $65.02 | $25K |
| 99204 Office E&M - New | Office | 252 | 252 | $120.06 | $30K |
| 92082 Vision, Hearing, and Speech Services | Office | 236 | 233 | $35.41 | $8,356 |
| 15823 Skin | Facility | 126 | 126 | $674.72 | $85K |
| 64612 Musculoskeletal | Office | 96 | 35 | $141.57 | $14K |
| 99203 Office E&M - New | Office | 75 | 75 | $76.42 | $5,731 |
| 99202 Office E&M - New | Office | 50 | 50 | $49.92 | $2,496 |
| 14060 Skin Grafting | Facility | 45 | 42 | $494.69 | $22K |
| 67904 Eye | Facility | 40 | 40 | $727.48 | $29K |
| 67917 Eye | Facility | 34 | 33 | $305.70 | $10K |
| 67924 Eye | Facility | 26 | 26 | $240.17 | $6,244 |
| 67840 Eye | Office | 23 | 23 | $230.37 | $5,299 |
| 68110 Eye | Office | 23 | 23 | $183.95 | $4,231 |
By year: 2022 $415K for 8,094 services; 2023 $365K for 9,146 services; 2024 $365K for 11,553 services.
Medicare prescription drug claims, 2024
In 2024, the drug Grant H Moore prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 894 prescriptions and refills. In total Grant H Moore wrote 1,417 Medicare prescriptions that cost $152K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 894 | 921 | 685 | $15K |
| Erythromycin Erythromycin Base | 198 | 206 | 145 | $3,333 |
| Ofloxacin Generic | 73 | 74 | 55 | $915 |
| Cephalexin Generic | 48 | 48 | 47 | $202 |
| Tramadol Hcl Generic | 44 | 44 | 44 | $94.15 |
| Doxycycline Hyclate Generic | 32 | 32 | 28 | $248 |
| Methylprednisolone Generic | 24 | 24 | 24 | $170 |
| Valacyclovir Valacyclovir Hcl | 18 | 18 | 17 | $225 |
| Fluticasone Propionate Generic | 11 | 15 | Under 11 | $143 |
Brand drugs: 424 claims; generic drugs: 993 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Grant H Moore $295 ($295 in general payments such as food, travel and fees) from 11 companies. The largest payer was Alcon Vision LLC with $32.65.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 1 | $32.65 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $32.07 |
| Amgen Inc. AMGN | 2 | $30.49 |
| Mallinckrodt Hospital Products Inc. | 1 | $28.15 |
| Abbvie Inc. ABBV | 1 | $26.96 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $26.83 |
| Dompe US, Inc. | 1 | $26.65 |
| Harrow Eye, LLC | 1 | $26.2 |
| Biotissue Holdings Inc. | 1 | $22.69 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $21.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.